Revenue has steadily increased over recent years, reaching $112 billion in Q2 2026 with consistent quarterly expansion. Operating income remains strong, though margins have seen some fluctuation due to cost pressures and investments in services. Net income margins around 4.9-6% reflect sustained profitability despite healthcare cost inflation and investments.

UnitedHealth's revenue growth is driven by expansion in both UnitedHealthcare insurance premiums and Optum’s service revenues. The balance between volume growth, pricing adjustments, and service segment growth enables stable revenue scaling. Recent quarters show a healthy 3-4% annual revenue growth trajectory, supported by diversified business lines.

Operating margins have varied from approximately 8% to lower single digits, with a slight decline comparing Q1 to Q2 2026 mostly due to numerator expense growth. Gross profit ratio remains above 30% in the latest quarter but has historically ranged in the 16%-24% range reflecting cost pressures and business mix. EBITDA margins remain solid around 8%-9% recently but are sensitive to service segment investments.

Earnings quality is high with solid cash flows implied by consistent profitability and controlled interest expenses. EPS growth is supported by both operational leverage and share count stability. The absence of significant one-time items suggests earnings are recurring and sustainable.

Year-over-year revenue growth has been steady between 3-6%, with Q2 2026 revenue increasing about 4.2% from the same quarter last year, underpinned by increased membership and service volume.

EPS has shown resilience with recent quarters reporting 6%-10% year-over-year growth, albeit with some variability due to macroeconomic factors affecting costs. Latest EPS of $6.05 beats estimates, reflecting operational strength.

Key growth drivers include expanding healthcare coverage memberships, growth in Optum’s data, pharmacy and care services, and continued leverage from technology and analytics-driven healthcare solutions.

Growth appears predominantly organic, supported by scale advantages and innovation in service offerings rather than heavy reliance on acquisitions, suggesting sustainable quality growth.

Gross margins have remained relatively consistent around 22-32% with signs of slight compression in gross profit due to cost inflation but stabilizing amid operational improvements. Operating margins have fluctuated around 7-8%, with net margins near 5-6%.

Return on equity and assets remain robust due to efficient capital deployment, although exact ROE/ROA data is not provided, stable net income and margins suggest strong returns likely in the mid-teens percentage range.

Margins face pressure from rising medical costs and regulatory challenges but the company's scale, service mix, and vertical integration provide resilience to maintain sustainable margins over the medium term.